G
Gideon Koren
Researcher at Ariel University
Publications - 2007
Citations - 88165
Gideon Koren is an academic researcher from Ariel University. The author has contributed to research in topics: Pregnancy & Population. The author has an hindex of 129, co-authored 1994 publications receiving 81718 citations. Previous affiliations of Gideon Koren include McGill University Health Centre & University of Western Ontario.
Papers
More filters
Journal ArticleDOI
A double-blind, placebo-controlled trial of transdermal fentanyl after abdominal hysterectomy. Analgesic, respiratory, and pharmacokinetic effects.
Alan N. Sandier,Alan D. Baxter,Joel Katz,Benoit Samson,Mark Friedlander,Peter H. Norman,Gideon Koren,Sandra Roger,Kathryn A. Hull,Julia Klein +9 more
TL;DR: A randomized, double-blind, placebo-controlled trial was conducted to assess the analgesic, pharmacokinetic, and clinical respiratory effects of 72-h application of two transdermal fentanyl patch sizes in patients undergoing abdominal hysterectomy.
Journal ArticleDOI
Hair analysis--a biological marker for passive smoking in pregnancy and childhood.
J Klein,Gideon Koren +1 more
TL;DR: The results show, that, despite the fact that parents of asthmatic children tend to smoke a lower number of cigarettes per day, their children had an average twofold higher concentrations of cotinine in their hair then the control, nonasthmatic children.
Journal ArticleDOI
Cyclosporin and quinidine inhibition of renal digoxin excretion : evidence for luminal secretion of digoxin
TL;DR: Results point to a luminal localization of this secretory system for renal digoxin secretion, and digoxin did not compete with [3H]azidopine for binding in rat brush-border membranes or membranes prepared from the multidrug-resistant cell line CHRC5.
Journal ArticleDOI
The protective effects of nausea and vomiting of pregnancy against adverse fetal outcome--a systematic review.
TL;DR: NVP is associated with favorable fetal outcome, and therefore studies of drug exposure in pregnancy should either match their exposed and control cases for existence and severity of NVP, or adjust for these confounders in their multivariate analysis.
Journal ArticleDOI
Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis
TL;DR: It is found that the significant risk signals began to emerge over the last 10–20 years even before large‐scale studies were performed, and VPA should not be used as a first‐line therapy in women of childbearing age unless it is the only option for the patient.